إعلان
إعلان

ASTH

ASTH logo

Astrana Health Inc. Common Stock

28.22
USD
برعاية
+0.06
+0.21%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

قبل الإفتتاح

28.25

+0.03
+0.09%

تقارير أرباح ASTH

النسبة الإيجابية المفاجئة

ASTH تفوق 18 من 30 آخر التقديرات.

60%

التقرير التالي

بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$949.07M
/
$0.10
التغير الضمني من Q3 25 (Revenue/ EPS)
-0.73%
/
+900.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+42.67%
/
-166.67%

Astrana Health Inc. Common Stock earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, ASTH reported earnings of 0.01 USD per share (EPS) for Q3 25, missing the estimate of 0.45 USD, resulting in a -97.78% surprise. Revenue reached 956.05 مليون, compared to an expected 971.84 مليون, with a -1.63% difference. The market reacted with a -23.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 المحللين forecast an EPS of 0.10 USD, with revenue projected to reach 949.07 مليون USD, implying an زيادة of 900.00% EPS, and نقصان of -0.73% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Astrana Health Inc. Common Stock reported EPS of $0.01, missing estimates by -97.78%, and revenue of $956.05M, -1.63% below expectations.
The stock price moved down -23.46%, changed from $33.36 before the earnings release to $25.54 the day after.
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
Based on 12 المحللين, Astrana Health Inc. Common Stock is expected to report EPS of $0.10 and revenue of $949.07M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان